BelHealth Investment Partners has promoted Jonathan Spero to Vice President. Mr. Spero joined BelHealth in 2015 and previously served as a senior associate and associate.
During his time at BelHealth, Mr. Spero has contributed to the firm in many ways including origination and structuring to due diligence, execution and portfolio company monitoring. He has supported the firm’s Fund II portfolio since inception and currently works with Village Fertility Pharmacy and Care Advantage. He is also active with some of BelHealth’s Fund I portfolio companies.
Mr. Spero has more than six years of experience working with healthcare services, products and distribution companies. Before joining BelHealth in 2015 he worked as an analyst in the healthcare investment banking division of SunTrust Robinson Humphrey where he focused on M&A, equity and leveraged finance transactions. He began his career at Schneider Downs Corporate Finance, a boutique investment bank focused on lower middle market M&A. Mr. Spero has a BS in Business Administration from Carnegie Mellon University.
“Jon has been a dedicated member of the BelHealth team for more than four years and it is great to see him advance in his career,” said Inder Tallur, senior managing director of BelHealth. “He has worked hard to develop a well-rounded skill set and is very deserving of this promotion. He will remain a key member of the team and is ready for increased responsibility as we move into the future at BelHealth.”
BelHealth invests from $20 million to $50 million in companies in three healthcare segments: services, products, and distribution. The firm is currently investing out of its second fund which closed in June 2015 at the hard cap of $350 million. Fund I was raised in 2012 with $150 million of committed capital. BelHealth is headquartered in New York (www.belhealth.com).
© 2019 Private Equity Professional | June 3, 2019
